Asia Healthcare Holdings (AHH), a single specialty investing and operating healthcare platform funded by TPG Growth and GIC, Singapore's sovereign wealth fund, has acquired  a majority stake in Asian Institute of Nephrology and Urology (AINU), India’s largest single specialty hospital network of Urology & Nephrology Care with a presence in four cities and pioneering work in Robotic Urology Surgery.

AHH will make an investment of Rs 600 crore in the company through a mix of primary and secondary infusion. This acquisition and AHH’s foray into Urology and Nephrology segment marks its expansion into a fourth speciality making it the largest and only single speciality healthcare delivery platform in India and the broader Asian sub-continent.

AINU currently operates seven hospitals across Hyderabad, Visakhapatnam, Siliguri and Chennai. The network has more than 500 beds, has treated more than 400,000 patients and completed over 50,000 procedures. AINU provides state-of-the-art treatment for urology conditions across its network. Its comprehensive services include diagnostics and treatment for stone disease, urology cancers, prostate diseases, reconstructive urology surgery, laparoscopic urology, and andrology. 

In 2022, India recorded approximately 1.89 crore Nephrology and Urology procedures and is projected to grow at a CAGR of 8-9% over the next five years making it one of the fastest growing specialties in the country. There are 6,000 qualified Urologists and 3,500 Nephrologists in India. Approximately 350 Urologists and 250 nephrologists graduate each year in India and the rise of laparoscopic, endoscopic and robotic surgical options gives a compelling growth opportunity for AINU to scale across the metros and tier 2 cities in the country.